Vimarsana
Biggest News Aggregation in the World

Junyan Zhang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Junyan Zhang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Junyan Zhang Today - Breaking & Trending Today

Exfoliating High-Quality h-BNNSs From h-BN Flakes - Vimarsana News

Exfoliating High-Quality h-BNNSs From h-BN Flakes

Chinese researchers have recently published a paper describing a novel mechanical approach for exfoliating hexagonal boron nitride nanosheets in a controlled manner (h-BNNSs).

ORNL: Novel composite catalyst holds promise for cost-effective ethanol-to-jet-fuel conversion - Vimarsana News

ORNL: Novel composite catalyst holds promise for cost-effective ethanol-to-jet-fuel conversion

Share Decarbonizing air transportation is critical to meeting U.S. climate goals and improving the nation’s energy economy. But technologies that are transforming automobiles – such as electric motors and hydrogen fuels – are difficult to implement in aircraft. A battery powerful enough to fuel an airplane would be prohibitively heavy. Hydrogen is only one quarter as energy dense as jet fuel (and many times more expensive) but would require large complex storage tanks onboard. To greatly reduce its emissions, the U.S. commercial aviation sector will need new methods of making sustainabl...

Researchers Identify Potential Targets for Novel Treatments for Lung Cancer - Vimarsana News

Researchers Identify Potential Targets for Novel Treatments for Lung Cancer

Date Time Researchers Identify Potential Targets for Novel Treatments for Lung Cancer Lung cancer is the most common cause of cancer deaths, accounting for about a third of all tumor-related deaths. Adenocarcinomas, a non-small cell lung cancer (NSCLC), account for about 40 percent of cancer diagnoses, but few treatments are available for the disease. A team of investigators led by Elena Levantini, PhD, a research associate in Hematology-Oncology in the laboratory of Daniel Tenen MD, at Beth Israel Deaconess Medical Center (BIDMC), evaluated a novel agent, PTC596, capable of decreasing tumor ...